Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 1, 1998, Pages 135-139

  Leeda, M ^a   Riyazi, N ^a   De Vries, J I P ^a   Jakobs, C ^a   Van Geijn, H P ^a   Dekker, G A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fetal growth restriction; Hyperhomocysteinemia; Preeclampsia; Pregnancy

Indexed keywords

FOLIC ACID; PYRIDOXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FETUS GROWTH; FETUS OUTCOME; HUMAN; HYPERHOMOCYSTEINEMIA; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; VITAMIN INTAKE;

EID: 0031828743     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70263-7     Document Type: Article

References (23)

1. Department of Health, Welsh Office, Scottish Home and Health Department, Department of Health and Social Services of Northern Ireland Report on confidential enquiries into maternal death in the United Kingdom: 1985-1987 1991 Her Majesty’s Stationery Office London
2. L Duley Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean Br J Obstet Gynaecol 99 1992 547 553
3. GA Dekker JIP de Vries PM Doelitzsch PC Huijgens BME von Blomberg C Jakobs Underlying disorders associated with severe early-onset preeclampsia Am J Obstet Gynecol 173 1995 1042 1048
4. RPM Steegers-Theunissen GHJ Boers JFM Trijbels Maternal hyperhomocysteinemia: a risk factor for neural tube defects Metabolism 43 1994 1475 1480
5. RPM Steegers-Theunissen GHJ Boers JMF Trijbels TKAB Eskes Hyperhomocysteinemia and recurrent abortion or abruptio placentae Lancet 339 1992 1122 1123
6. MGAJ Wouters GHJ Boers HJ Blom Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss Fertil Steril 60 1993 820 825
7. TAW Goddijn-Wessel MGAJ Wouters EF vd Molen MDEH Spuijbroek RPM Steegers-Theunissen HJ Blom Hyperhomocysteinemia: a risk factor for placental abruption or infarction Eur J Obstet Gynecol Reprod Biol 66 1996 23 29
8. GA Dekker HP van Geijn Endothelial dysfunction in preeclampsia. Part I: Primary prevention: therapeutic perspectives J Perinat Med 24 1996 99 117
9. GA Dekker HP van Geijn Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia: therapeutic perspectives J Perinat Med 24 1996 119 139
10. RPM Steegers-Theunissen GHJ Boers EAP Steegers JMF Trijbels CMG Thomas TKAB Eskes Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study Contraception 45 1992 129 139
11. GJ Kloosterman The significance of prenatal care Int J Gynaecol Obstet 8 1970 895 912
12. SH Mudd F Skovby HL Levy The natural history of homocysteinuria due to cystathionine-synthase deficiency Am J Hum Genet 37 1985 1 31
13. JB Ubbink WJK Vermaak S Bissbort Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum J Chromatogr 565 1991 441 446
14. 6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia J Vasc Surg 20 1994 933 940
15. MR Malinow SS Kang LM Taylor Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease Circulation 79 1989 1180 1188
16. R Clarke L Daly K Robinson Hyperhomocysteinemia: an independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
17. JM Roberts CWG Redman Pre-eclampsia: more than pregnancy-induced hypertension Lancet 341 1994 1447 1454
18. Sh Mudd HL Levy F Skovby Disorders of transsulfuration CR Scriver AL Beaudet WS Sly The metabolic basis of inherited disease 1989 McGraw-Hill New York 693 734
19. GHJ Boers Homocystinuria; a risk factor of premature vascular disease 1986 Foris Publications Dordrecht-Holland/Riverton USA 52 56 Clin Res Series No. 3
20. G Burke K Robinson H Refsum B Stuart J Drumm I Graham Intrauterine growth retardation, perinatal death, and maternal homocysteine levels N Engl J Med 326 1992 69 70
21. GG Briggs RK Freeman SJ Yaffe Drugs in pregnancy and lactation 1994 Williams & Wilkins Baltimore 378 392
22. GG Briggs RK Freeman SJ Yaffe Drugs in pregnancy and lactation 1994 Williams & Wilkins Baltimore 747 754
23. P Frosst HJ Blom R Milos P Goyette CA Sheppard RG Matthews A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase locus Nat Genet 10 1995 111 113